B cells contribute to heterogeneity of IL-17 producing cells in rheumatoid arthritis and healthy controls

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Schlegel, Paul Martin ^a   Steiert, Ingeborg ^a   Kötter, Ina ^a   Müller, Claudia A ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 17; IONOMYCIN; PHORBOL 13 ACETATE 12 MYRISTATE;

ADULT; AGED; ARTICLE; B LYMPHOCYTE; BONE MARROW CELL; CELL DIFFERENTIATION; CELL SELECTION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; FLOW CYTOMETRY; FLUORESCENCE; HUMAN; HUMAN CELL; INNATE IMMUNITY; MALE; NATURAL KILLER CELL; PATHOGENESIS; PERIPHERAL BLOOD MONONUCLEAR CELL; POLYMERASE CHAIN REACTION; RHEUMATOID ARTHRITIS; TH17 CELL;

ADULT; AGED; ARTHRITIS, RHEUMATOID; B-LYMPHOCYTES; GENE EXPRESSION REGULATION; HUMANS; IMMUNITY, INNATE; INTERLEUKIN-17; KILLER CELLS, NATURAL; MALE; MIDDLE AGED; MYELOID CELLS; TH17 CELLS;

EID: 84891937241     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0082580     Document Type: Article

References (63)

1. Rouvier E, Luciani MF, Mattéi MG, Denizot F, Golstein P (1993) CTLA-8, cloned from an activated T cell, bearing AU-rich messenger RNA instability sequences, and homologous to a herpesvirus Saimiri gene. J Immunol 150: 5445-5456. PubMed: 8390535. (Pubitemid 23180658)
2. Wright JF, Bennett F, Li B, Brooks J, Luxenberg DP et al. (2008) The human IL-17F/IL-17A heterodimeric cytokine signals through the IL-17RA/IL-17RC receptor complex. J Immunol 181: 2799-2805. PubMed: 18684971.
3. Weaver CT, Hatton RD, Mangan PR, Harrington LE (2007) IL-17 Family Cytokines and the Expanding Diversity of Effector T Cell Lineages. Annu Rev Immunol 25: 821-852. doi:10.1146/annurev.immunol.25.022106.141557. PubMed: 17201677. (Pubitemid 46697925)
4. Umemura M, Yahagi A, Hamada S, Begum MD, Watanabe H et al.(2007) IL-17-mediated regulation of innate and acquired immune response against pulmonary Mycobacterium bovis bacille Calmette- Guerin infection. J Immunol 178: 3786-3796. PubMed: 17339477. (Pubitemid 46417647)
5. Harrington LE, Hatton RD, Mangan PR, Turner H, Murphy TL et al.(2005) Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 6: 1123-1132. doi:10.1038/ni1254. PubMed: 16200070. (Pubitemid 41541790)
6. Park H, Li Z, Yang XO, Chang SH, Nurieva R et al. (2005) A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol 6: 1133-1141. doi:10.1038/ni1261. PubMed: 16200068. (Pubitemid 41541791)
7. Ivanov II, McKenzie BS, Zhou L, Tadokoro CE, Lepelley A et al. (2006) The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 126: 1121-1133. doi:10.1016/j.cell. 2006.07.035. PubMed: 16990136. (Pubitemid 44380299)
8. Veldhoen M, Hocking RJ, Atkins CJ, Locksley RM, Stockinger B (2006) TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 24: 179-189. doi:10.1016/j.immuni.2006.01.001. PubMed: 16473830. (Pubitemid 43214587)
9. Mangan PR, Harrington LE, O'Quinn DB, Helms WS, Bullard DC et al. (2006) Transforming growth factor-beta induces development of the T(h)17 lineage. Nature 441: 231-234. doi:10.1038/nature04754. PubMed: 16648837.
10. Bettelli E, Carrier Y, Gao W, Korn T, Strom TB et al. (2006) Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441: 235-238. doi:10.1038/nature04753. PubMed: 16648838.
11. Kondo T, Takata H, Matsuki F, Takiguchi M (2009) Cutting edge: Phenotypic characterization and differentiation of human CD8+ T cells producing IL-17. J Immunol 182: 1794-1798. doi:10.4049/jimmunol. 0801347. PubMed: 19201830.
12. O'Brien RL, Roark CL, Born WK (2009) IL-17-producing gammadelta T cells. Eur J Immunol 39: 662-666. doi:10.1002/eji.200839120. PubMed: 19283718.
13. Takatori H, Kanno Y, Watford WT, Tato CM, Weiss G et al. (2009) Lymphoid tissue inducer-like cells are an innate source of IL-17 and IL-22. J Exp Med 206: 35-41. doi:10.1084/jem.20072713. PubMed: 19114665.
14. Bird L (2008) NKT cells: NKT cells join the IL-17 gang. Nature Reviews Immunology 8: 324. doi:10.1038/nri2325. (Pubitemid 351595227)
15. Michel JJ, Turesson C, Lemster B, Atkins SR, Iclozan C et al. (2007) Identification of an IL-17-producing NK1.1(neg) iNKT cell population involved in airway neutrophilia. J Exp Med 204: 995-1001. doi:10.1084/jem.20061551. PubMed: 17470641.
16. Fujino S, Andoh A, Bamba S, Ogawa A, Hata K et al. (2003) Increased expression of interleukin 17 in inflammatory bowel disease. Gut 52: 65-70. doi:10.1136/gut.52.1.65. PubMed: 12477762. (Pubitemid 36020767)
17. Hoshino A, Nagao T, Nagi-Miura N, Ohno N, Yasuhara M et al. (2008) MPO-ANCA induces IL-17 production by activated neutrophils in vitro via classical complement pathway-dependent manner. J Autoimmun 31: 79-89. doi:10.1016/j.jaut.2008.03.006. PubMed: 18501296. (Pubitemid 351685761)
18. Lin AM, Rubin CJ, Khandpur R, Wang JY, Riblett M et al. (2011) Mast cells and neutrophils release IL-17 through extracellular trap formation in psoriasis. J Immunol 187: 490-500. doi:10.4049/jimmunol.1100123. PubMed: 21606249.
19. Bermejo DA, Jackson SW, Gorosito-Serran M, Acosta-Rodriguez EV, Amezcua-Vesely MC et al. (2013) Trypanosoma cruzi trans-sialidase initiates a program independent of the transcription factors RORγt and Ahr that leads to IL-17 production by activated B cells. Nat Immunol 14: 514-522. doi:10.1038/ni.2569. PubMed: 23563688.
20. Lubberts E, Joosten LA, Oppers B, van den Bersselaar L, Coenen-de Roo CJ et al. (2001) IL-1-independent role of IL-17 in synovial inflammation and joint destruction during collagen-induced arthritis. J Immunol 167: 1004-1013. PubMed: 11441109. (Pubitemid 32660858)
21. Lubberts E, Koenders MI, van den Berg WB (2005) The role of T-cell interleukin-17 in conducting destructive arthritis: lessons from animal models. Arthritis Res Ther 7: 29-37. doi:10.1186/ar1550. PubMed:15642151. (Pubitemid 40214525)
22. Chabaud M, Lubberts E, Joosten L, van den Berg W, Miossec P (2001) IL-17 derived from juxta-articular bone and synovium contributes to joint degradation in rheumatoid arthritis. Arthritis Res 3: 168-177. doi: 10.1186/ar294. PubMed: 11299057. (Pubitemid 32303433)
23. Shahrara S, Huang Q, Mandelin AM 2nd, Pope RM (2008) TH-17 cells in rheumatoid arthritis. Arthritis Res Ther 10: R93. doi:10.1186/ar2477. PubMed: 18710567.
24. Ziolkowska M, Koc A, Luszczykiewicz G, Ksiezopolska-Pietrzak K, Klimczak E et al. (2000) High levels of IL-17 in rheumatoid arthritis patients: IL-15 triggers in vitro IL-17 production via cyclosporin Asensitive mechanism. J Immunol 164: 2832-2838. PubMed: 10679127. (Pubitemid 30115519)
25. Chabaud M, Durand JM, Buchs N, Fossiez F, Page G et al. (1999) Human interleukin-17: A T cell-derived proinflammatory cytokine produced by the rheumatoid synovium. Arthritis Rheum 42: 963-970. doi:10.1002/1529-0131(199905) 42:5. PubMed: 10323452. (Pubitemid 29215007)
26. Kotake S, Udagawa N, Takahashi N, Matsuzaki K, Itoh K et al. (1999) IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. J Clin Invest 103: 1345-1352. doi: 10.1172/JCI5703. PubMed: 10225978. (Pubitemid 29218305)
27. Church LD, Filer AD, Hidalgo E, Howlett KA, Thomas AMC et al. (2010) Rheumatoid synovial fluid interleukin-17-producing CD4 T cells have abundant tumor necrosis factor-alpha co-expression, but little interleukin-22 and interleukin-23R expression. Arthritis Res Ther 12: R184. doi:10.1186/ar3152. PubMed: 20929536.
28. Appel H, Maier R, Wu P, Scheer R, Hempfing A et al. (2011) Analysis of IL-17(+) cells in facet joints of patients with spondyloarthritis suggests that the innate immune pathway might be of greater relevance than the Th17-mediated adaptive immune response. Arthritis Res Ther 13: R95. doi:10.1186/ar3370. PubMed: 21689402.
29. Yamada H, Nakashima Y, Okazaki K, Mawatari T, Fukushi JI et al. (2008) Th1 but not Th17 cells predominate in the joints of patients with rheumatoid arthritis. Ann Rheum Dis 67: 1299-1304. PubMed: 18063670.
30. Hueber AJ, Asquith DL, Miller AM, Reilly J, Kerr S et al. (2010) Mast cells express IL-17A in rheumatoid arthritis synovium. J Immunol 184: 3336-3340. doi:10.4049/jimmunol.0903566. PubMed: 20200272.
31. Colin EM, Asmawidjaja PS, van Hamburg JP, Mus AMC, van Driel M et al. (2010) 1,25-dihydroxyvitamin D3 modulates Th17 polarization and interleukin-22 expression by memory T cells from patients with early rheumatoid arthritis. Arthritis Rheum 62: 132-142. doi:10.1002/art. 25043. PubMed: 20039421.
32. Shen H, Goodall JC, Hill Gaston JS (2009) Frequency and phenotype of peripheral blood Th17 cells in ankylosing spondylitis and rheumatoid arthritis. Arthritis Rheum 60: 1647-1656. doi:10.1002/art.24568. PubMed: 19479869.
33. Jandus C, Bioley G, Rivals J-P, Dudler J, Speiser D et al. (2008) Increased numbers of circulating polyfunctional Th17 memory cells in patients with seronegative spondylarthritides. Arthritis Rheum 58: 2307-2317. doi:10.1002/art.23655. PubMed: 18668556.
34. Hochberg MC, Chang RW, Dwosh I, Lindsey S, Pincus T, et al. (1992) The American College of Rheumatology 1991 revised criteria for the classification of global functional status in rheumatoid arthritis. Arthritis Rheum 35: 498-502
35. Morbach H, Eichhorn EM, Liese JG, Girschick HJ (2010) Reference values for B cell subpopulations from infancy to adulthood. Clin Exp Immunol 162: 271-279. doi:10.1111/j.1365-2249.2010.04206.x. PubMed: 20854328.
36. Weyand CM, Goronzy J, Fathman CG (1987) Modulation of CD4 by antigenic activation. J Immunol 138: 1351-1354. PubMed: 3100638. (Pubitemid 17029425)
37. Chang Y, Nadigel J, Boulais N, Bourbeau J, Maltais F et al. (2011) CD8 positive T cells express IL-17 in patients with chronic obstructive pulmonary disease. Respir Res 12: 43. doi:10.1186/1465-9921-12-43. PubMed: 21477350.
38. Roark CL, Simonian PL, Fontenot AP, Born WK, O'Brien RL (2008) gammadelta T cells: an important source of IL-17. Curr Opin Immunol 20: 353-357. doi:10.1016/j.coi.2008.03.006. PubMed: 18439808.
39. Hitchon CA, El-Gabalawy HS (2011) Infection and rheumatoid arthritis:still an open question. Curr Opin Rheumatol 23: 352-357. doi:10.1097/BOR.0b013e3283477b7b. PubMed: 21532483.
40. Suurmond J, Dorjée AL, Boon MR, Knol EF, Huizinga TW et al. (2011) Mast cells are the main interleukin 17-positive cells in anticitrullinated protein antibody-positive and -negative rheumatoid arthritis and osteoarthritis synovium. Arthritis Res Ther 13: R150. doi:10.1186/ar3466. PubMed: 21933391.
41. Chen D-Y, Chen Y-M, Chen H-H, Hsieh C-W, Lin C-C et al. (2011) Increasing levels of circulating Th17 cells and interleukin-17 in rheumatoid arthritis patients with an inadequate response to anti-TNF-αtherapy. Arthritis Res Ther 13: R126. doi:10.1186/ar3431. PubMed: 21801431.
42. Aerts NE, De Knop KJ, Leysen J, Ebo DG, Bridts CH et al. (2010) Increased IL-17 production by peripheral T helper cells after tumour necrosis factor blockade in rheumatoid arthritis is accompanied by inhibition of migration-associated chemokine receptor expression. Rheumatology (Oxford) 49: 2264-2272. doi:10.1093/rheumatology/keq224. PubMed: 20724433.
43. Chakir J, Shannon J, Molet S, Fukakusa M, Elias J et al. (2003) Airway remodeling-associated mediators in moderate to severe asthma: effect of steroids on TGF-beta, IL-11, IL-17, and type I and type III collagen expression. J Allergy Clin Immunol 111: 1293-1298. doi:10.1067/mai. 2003.1557. PubMed: 12789232. (Pubitemid 36683685)
44. Liu X, Yang P, Lin X, Ren X, Zhou H et al. (2009) Inhibitory effect of Cyclosporin A and corticosteroids on the production of IFN-gamma and IL-17 by T cells in Vogt-Koyanagi-Harada syndrome. Clin Immunol 131: 333-342. doi:10.1016/j.clim.2008.12.007. PubMed: 19200788.
45. Miranda-Carús ME, Benito-Miguel M, Balsa A, Cobo- Ibáñez T, Pérez de Ayala C et al. (2006) Peripheral blood T lymphocytes from patients with early rheumatoid arthritis express RANKL and interleukin-15 on the cell surface and promote osteoclastogenesis in autologous monocytes. Arthritis Rheum 54: 1151-1164. doi:10.1002/art.21731. PubMed: 16575870. (Pubitemid 43672928)
46. Marston B, Palanichamy A, Anolik JH (2010) B cells in the pathogenesis and treatment of rheumatoid arthritis. Curr Opin Rheumatol 22 %W http://view.ncbi.nlm.nih.gov/pubmed/20090526: 307-315
47. Takemura S, Klimiuk PA, Braun A, Goronzy JJ, Weyand CM (2001) T cell activation in rheumatoid synovium is B cell dependent. J Immunol 167: 4710-4718. PubMed: 11591802. (Pubitemid 32954353)
48. O'Neill SK, Shlomchik MJ, Glant TT, Cao Y, Doodes PD et al. (2005) Antigen-specific B cells are required as APCs and autoantibodyproducing cells for induction of severe autoimmune arthritis. J Immunol 174: 3781-3788. PubMed: 15749919. (Pubitemid 40354091)
49. Gavanescu I, Benoist C, Mathis D (2008) B cells are required for Airedeficient mice to develop multi-organ autoinflammation: A therapeutic approach for APECED patients. Proc Natl Acad Sci U S A 105: 13009-13014. doi:10.1073/pnas.0806874105. PubMed: 18755889.
50. Wilson CL, Hine DW, Pradipta A, Pearson JP, van Eden W et al. (2012) Presentation of the candidate rheumatoid arthritis autoantigen aggrecan by antigen-specific B cells induces enhanced CD4(+) T helper type 1 subset differentiation. Immunology 135: 344-354. doi: 10.1111/j.1365-2567.2011.03548.x. PubMed: 22182481.
51. Duddy ME, Alter A, Bar-Or A (2004) Distinct profiles of human B cell effector cytokines: a role in immune regulation? J Immunol 172: 3422-3427. PubMed: 15004141. (Pubitemid 38337921)
52. Capolunghi F, Cascioli S, Giorda E, Rosado MM, Plebani A et al. (2008) CpG drives human transitional B cells to terminal differentiation and production of natural antibodies. J Immunol 180: 800-808. PubMed: 18178818.
53. Mauri C, Bosma A (2012) Immune regulatory function of B cells. Annu Rev Immunol 30: 221-241. doi:10.1146/annurevimmunol- 020711-074934. PubMed: 22224776.
54. Flores-Borja F, Bosma A, Ng D, Reddy V, Ehrenstein MR et al. (2013) CD19+CD24hiCD38hi B cells maintain regulatory T cells while limiting TH1 and TH17 differentiation. Sci Transl Med 5: 173ra123. PubMed: 23427243.
55. Souto-Carneiro MM, Mahadevan V, Takada K, Fritsch-Stork R, Nanki T et al. (2009) Alterations in peripheral blood memory B cells in patients with active rheumatoid arthritis are dependent on the action of tumour necrosis factor. Arthritis Res Ther 11: R84. doi:10.1186/ar2718. PubMed: 19500335.
56. León B, Lund FE (2013) IL-17-producing B cells combat parasites. Nat Immunol 14: 419-421. doi:10.1038/ni.2593. PubMed: 23598388.
57. Szodoray P, Jonsson R (2005) The BAFF/APRIL system in systemic autoimmune diseases with a special emphasis on Sjogren's syndrome. Scand J Immunol 62: 421-428. doi:10.1111/j.1365-3083.2005.01688.x. PubMed: 16305638. (Pubitemid 41719317)
58. Mariette X, Roux S, Zhang J, Bengoufa D, Lavie F et al. (2003) The level of BLyS (BAFF) correlates with the titre of autoantibodies in human Sjogren's syndrome. Ann Rheum Dis 62: 168-171. doi:10.1136/ard.62.2.168. PubMed: 12525388. (Pubitemid 36135394)
59. Bosello S, Youinou P, Daridon C, Tolusso B, Bendaoud B et al. (2008) Concentrations of BAFF correlate with autoantibody levels, clinical disease activity, and response to treatment in early rheumatoid arthritis. J Rheumatol 35: 1256-1264. PubMed: 18528969. (Pubitemid 352000768)
60. Genovese MC, Fleischmann RM, Greenwald M, Satterwhite J, Veenhuizen M et al. (2013) Tabalumab, an anti-BAFF monoclonal antibody, in patients with active rheumatoid arthritis with an inadequate response to TNF inhibitors. Ann Rheum Dis 72: 1461-1468. doi: 10.1136/annrheumdis-2012-202775. PubMed: 23268367.
61. Kwan Lam Lai, King Hung Ko O, Zheng BJ, Lu L (2008) Local BAFF gene silencing suppresses Th17-cell generation and ameliorates autoimmune arthritis. Proc Natl Acad Sci U S A 105: 14993-14998. doi: 10.1073/pnas.0806044105. PubMed: 18820032.
62. Doreau A, Belot A, Bastid J, Riche B, Trescol-Biemont MC et al. (2009) Interleukin 17 acts in synergy with B cell-activating factor to influence B cell biology and the pathophysiology of systemic lupus erythematosus. Nat Immunol 10: 778-785. doi:10.1038/nrm2786. PubMed: 19483719.
63. Korhonen R, Moilanen E (2010) Anti-CD20 antibody rituximab in the treatment of rheumatoid arthritis. Basic Clin Pharmacol Toxicol 106: 13-21. PubMed: 19686542.